Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.
Open Access
- 1 June 1975
- journal article
- clinical trial
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 38 (6) , 592-597
- https://doi.org/10.1136/jnnp.38.6.592
Abstract
Cyclophosphamide (CY) has been shown to reverse the signs of experimental allergic encephalomyelitis (EAE) even after the onset of neurological deficits. Because of the analogy of EAE to exacerbations of multiple sclerosis (MS) a clinical trial of CY in acute MS exacerbations was undertaken. A 'sequential criterion' method was used to minimize the size of sample needed for this pilot study. CY failed to alter significantly the course of acute exacerbations of MS. Possible reasons for this failure, and the value of the sequential criterion method in pilot studies, are discussed.Keywords
This publication has 15 references indexed in Scilit:
- ÆTIOLOGY OF MULTIPLE SCLEROSISThe Lancet, 1974
- Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosisNeurology, 1973
- Multiple sclerosis: An immunologic reassessmentJournal of Chronic Diseases, 1973
- Multiple Sclerosis Unaffected by Azathioprine in Pilot StudyArchives of Neurology, 1973
- Cyclophosphamide: Effect on Experimental Allergic Encephalomyelitis in Lewis RatsScience, 1969
- CYCLOPHOSPHAMIDE IN MULTIPLE SCLEROSISThe Lancet, 1969
- Chemical Suppression of Adaptive ImmunityPublished by Elsevier ,1967
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965
- TISSUE CULTURE STUDIES OF DEMYELINATION*Annals of the New York Academy of Sciences, 1965
- SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITESAnnals of the New York Academy of Sciences, 1965